Information for Press

Media Invite

We hereby would like to invite you to attend the 16th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2023), which takes place from 22-25 February 2023, in Berlin & Online.

Innovation in diabetes medicines and treatments, the most cutting-edge technologies, and the latest research. The field continues to move forward at full speed, and ATTD is at the forefront of those changes.

We invite you to join us and take part in the future.

Details about the program and press releases with the latest updates will be shared with you closer towards the Conference.

We look forward to seeing you at ATTD!

Press Registration

We offer complimentary registration for members of the press. However, press credentials are required.

To register, please send us valid press ID card or a letter from the publisher of the institution/journal you are working for by email to: reg_attd23@kenes.com Please, make sure you specify your full name and address.

Embargo Policy

All abstracts and oral presentations are under embargo until the start of the ATTD 2023 Conference. The embargo will be lifted on 22 February 2023 at 09:00 CET.

We produce and distribute press releases summarizing upcoming content that will be presented at ATTD 2023. Parts of the content in the press releases, which refer to industry news and presented scientific papers, will be embargoed until the time and date clearly stated on the press release.

Our policy is to release information about the content presented at ATTD 2023 in a way that provides fair and equal access to all media representatives, allowing them to understand the most up-to-date version of the scientific findings that are to be presented. Media representatives and their institutions’ press offices are encouraged to interact with the ATTD 2023 Communication Team ahead of publication, and benefit from the subsequent coverage.

Abstracts will be available in the Diabetes Technology & Therapeutics Journal at the start of the ATTD 2023 Conference starts on 22 February 2023.

The 14^th ATTD Yearbook, the 2022 Yearbook, will be made available online from 22^nd of February.

Photography & videography

Photography and videography are permitted at the ATTD 2023 Event only for registered media representatives. You are authorized to collect video material as follows:

-In the lobby, exhibition area and all common spaces outside the session halls.

-In the session halls, during the first 5 minutes of any session from the front of the room unless you are specifically asked NOT to film by the speaker/chair/company representative.

After 5 minutes, no flash photography will be allowed, and cameras will need to be removed from the front of the room.

-If you are staying after the first 5 minutes, you must have a seat in the audience.

Interviews

You are allowed to arrange and conduct interviews with speakers and others at the ATTD Conference. Unfortunately, the ATTD organizers and communication team cannot assist with the arrangements.

As part of the authorization, we request you reference the content collected at ATTD 2023 and share it with us after it is published. We will happily re-share your content upon request on appropriate channels.

A selection of abstract authors have given authorization to share their contact details with the press for inquiries and potential interview requests. In case of interest, reach out to us to receive those details.

Press Releases

To subscribe to press news – reach out to ybraun@kenes.com

Press releases from the official ATTD channels, as well as partners who’ve asked to share their news with the press, will be published here.

ATTD 2023 Kicks Off in Berlin

22 February 2023

The 16th International Conference on Advanced Technologies & Treatments for Diabetes brings together the world’s leading experts on diabetes technology and treatment.

The 16th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2023), the leading conference on developments in diabetes treatments and technology, is kicking off today. From the 22^nd of February until the 25^th, over 3900 international participants, experts and industry leaders are gathering in Berlin to discuss the latest updates in the field.

Unique about the ATTD Conference is the focus on new technologies and medical devices. The International Fair of New Technologies in Diabetes has grown into a platform for start-ups to showcase their advanced scientific knowledge and technological achievements, to promote and enhance their development, gain feedback and make contacts to further develop it. Support and visibility will help fuel opportunities for the Tech Fair participants.

Conference Co-Chair, Professor Moshe Phillip said of the ATTD Tech Fair, “ATTD is the right platform for bringing together researchers from academic world, key opinion leaders and inventors for exchanging view and ideas. It creates a link between new inventions to potential industrial companies, venture capital and investors interested in funding further developments, or commercialization of inventions or products.”

Conference Chairs Prof. Moshe Phillip and Prof. Tadej Battelino are hosting their 16^th meeting, that continues to grow and inspire. With the wider goal to create a community of like-minded professionals that together strive to change the lives of people with diabetes, they continue to present a meeting that holds that objective in mind.

The Conference program offers a variety of scientific sessions focusing on the latest research data. Contributed to the program are nearly 700 abstract submissions. Session topics include digital clinics, decision support systems/advisors, big data and artificial intelligence-based decision support systems, glucose sensors, closed-and open-loop systems, artificial pancreas, devices for diabetic prevention, new insulins and new medications, insulin pumps, and more.

Professor Moshe Phillip continued, “Diabetes technology is maturing. We must perfect it and make it really accessible in day-to-day life for most people with diabetes. The health-care professionals must partner more than ever with innovators and manufacturers in the process of wide-spread implementation and continuous improvement of the technology and treatments for improving the life of people with diabetes.”

ATTD Yearbook

The ATTD Conference goes hand in hand with the publication of the ATTD Yearbook. The 14^th Yearbook (ATTD 2022 Yearbook) is available via the ATTD Conference website and the website of the publisher, Mary Ann Liebert, Inc., as of the first day of the meeting.

The speed of developments of new and advanced technologies and devices for the treatment of diabetes annually results in numerous manuscripts in medical journals, and the Yearbook summarizes the most important articles in the field.

One of the highlights of the Conference is the ATTD Yearbook session, that will take place on Friday the 24^th of February. Authors of the book will each present their chapter in a session that will give you all you need to know about the main findings and changes in the diabetes field.

Awards

During the closing ceremony, the 2023 Insulin Centennial Award will be awarded. Following a 3-year celebration around the 100 year insulin anniversary, this Insulin Centennial Award is an initiative of ATTD in collaboration with Lilly Diabetes, to recognize the value and importance of continued innovation in diabetes, and award an exemplary individual for their work within diabetes innovation.

About ATTD

The International Conference on Advanced Technologies and Treatments for Diabetes (ATTD) was established in 2008 with the aim to connect clinicians, scientists, engineers, medical corporations, investors, start-ups, regulators, and individuals with diabetes to facilitate the development and implementation of novel diabetes technologies, medications, and integrated treatment solutions. Distinguished international professionals discuss and disseminate information on the latest technologies and treatments in our field.

The ATTD Education Portal is a supporting activity of the ATTD annual conferences, that offers continuous education for the ATTD and diabetes community. Conference materials, e-learning modules, webcasts and industry materials are freely accessible to all. The ATTD Education Portal is now powered by UNLOK, an easy-to-use platform that helps medical professionals access innovative, effective, and multi-disciplinary digital education.

Contact

Yulia Braun – ybraun@kenes.com

ATTD Communications Team

Trailblazing Innovations at the ATTD Technology Fair

22 February 2023

The 16th International Conference on Advanced Technologies & Treatments for Diabetes brings together the world’s leading experts on diabetes technology and treatment.

ATTD 2023 is hosting once again its successful International Technology Fair of New Technologies in Diabetes – the one-of-a-kind event that brings together the latest discoveries and technological advances in the field of diabetes.

The Tech Fair gives the spotlight to start-ups, research centers and companies with products in the pipeline to promote their advances and achievements, so they can get feedback and contacts to speed up development and improve their inventions.

ATTD has been providing a platform to start-ups in the diabetes field, which has been leading to breakthrough developments and innovations in the treatment of diabetes.

‘’Most great ideas come out of interaction with people, away from the focus of what you usually do. Brainstorming of this kind leads to new inventions. The Technology Fair facilitates that, and therefore, is an incubator for great ideas’’ – Prof. Moshe Phillip, ATTD Conference Co-Chair.

Prof. Phillip continued, “We’re proudly offering this stage and are happy to see success stories coming from past Tech Fair participants, whether that is due to the products becoming available for daily use for people with diabetes, or acquisitions of emerging companies. By offering support, input and visibility, diabetes start-ups are given a push to help accelerate their innovative work.”

This year, 30 start-up companies are participating in the 2023 International Fair of New Technologies. The Tech Fair companies will present their developments in the Tech Fair area, every day, during the official program break times.

14 promising start-ups have been further awarded ATTD Start-Up Grants. We also invite you to watch the grant winning companies’ presentations at the virtual session on the ATTD platform. The winners are:

Balance Health is making it possible for patients to have virtual consultations with a team of diabetes experts using new technology.

DiabetesWise is a free, unbranded, data-driven online resource that provides comprehensive tools to explore diabetes devices with regulatory approval. It is funded by the Helmsley Charitable Trust with no financial support from device manufacturers.

Diatech Diabetes has developed SmartFusion™, an infusion monitoring software that detects insulin delivery failure, provides insights on how infusion performance affects diabetes management.

DN Care is a startup company that has developed a portable device that simultaneously measures foot pressure and temperature to diagnose diabetic foot neuropathy and provide treatment through light therapy.

GLAICE provides personalized exercise support for people with type-1 diabetes through an app that offers tailored advice based on medical research and user data.

GluCare is a hybrid Digital Therapeutics (DTx)+Human metabolic health platform offers personalized care through continuous metabolic monitoring, wearable technology, data analytics, and expert support.

Harald AI’s Happy Bob App is a user-friendly diabetes management tool that turns real-time health data into engaging and rewarding experiences, it’s available for download on iOS, Android, and Apple Watch in seven languages.

HEAL.med’s Deapp, a Diabetes Education Application, aims to ensure every child diagnosed with Type-1 diabetes has access to high-quality and effective education.

Sendo Diabetes is a Personal Coaching system that prescribes personalized nutrition, physical activity, and lifestyle advice using AI-powered technology and real-time adaptability.

Medtech Concept LLC is a healthcare and life science company based in USA focused on diabetes healthcare. Innovating medical products for diabetics.

Open MedLabs, a startup from IISc, Bangalore, designs and develops medical devices for resource-constrained settings. Open-source communities reduce device and service costs, maximising healthcare system return on investment.

Replica is the search and recommendation engine for your metabolism. By learning from your data, Replica will model how your metabolism reacts to different foods and activities.

SmartStart Health is developing SmartStart CGM, a CGM education and onboarding app. SmartStart CGM is simple, engaging, relevant, fun, and beautiful. Time- and cost-efficient.

The validated Spotlight-AQ digital health platform provides true person-centred healthcare and improved physical and mental health outcomes for adults with type 1 or type 2 diabetes, children with type 1 diabetes and their parents or caregivers, and obese people.

Please read about all the ATTD Tech Fair participants here: https://attd.kenes.com/tech-fair-sessions-timetable/
About ATTD

The ATTD Education Portal is a supporting activity of the ATTD annual conferences. It offers continuous education for the ATTD and diabetes community: Conference materials, e-learning modules, webcasts and industry materials are freely accessible to all. The ATTD Education Portal is now powered by UNLOK, an easy-to-use platform that helps medical professionals access innovative, effective, and multi-disciplinary digital education.